Cancer vaccine sustains 49% melanoma reduction after 5 years

The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful in cutting the risk of skin cancer recurrence and death by 49%, a new study shows. This reduction was calculated five years after patients had their tumors surgically removed and remains unchanged.